Neurobehavioral Family Study of Schizophrenia is a Multiplex Multigenerational Investigation (MGI) of three collaborative RO1s that combine genetic and neurobiologic paradigms to advance the understanding of pathogenesis and detection of genes that modulate susceptibility to schizophrenia (SCZ). Complex genetic mechanisms underlie the susceptibility to SCZ. Paralleling the progress in genetics, neurobiologic studies have identified neural systems that could provide pathophysiologic substrates for focused investigations. We have established a sample of multigenerational multiplex families that were ascertained, phenotypically characterized and genotyped for genome-wide linkage analyses. This sample was examined with a computerized neurocognitive battery that provides complementary quantitative phenotypes to diagnosis. We observed significant heritability for several neurocognitive domains as well as evidence for linkage. Our goal for the renewal application is to capitalize on this unique sample and obtain neuroimaging phenotypes of brain structure and function with Magnetic Resonance Imaging (MRI). We will examine brain structure using volume-based morphometry and connectivity with Diffusion Tensor Imaging (DTI). Functional MRI (fMRI) studies will examine brain circuitry activated in response to neurobehavioral probes. We will follow 300 individuals from the MGI sample for neuroimaging studies. We will also ascertain a new population-based sample of 300 community controls (Specific Aim 1). We will relate the heritability of neuroimaging phenotypes to symptom and neurobehavioral measures and perform multivariate quantitative genetic analyses to identify quantitative phenotypes influenced by the same genes (Specific Aim 2). To establish genetic mechanisms producing the neurobehavioral and neuroimaging phenotypes we will localize new quantitative trait loci through genome-wide association (GWA) analyses and follow-up significant linkage and GWA analysis signals as well as candidate genes identified through ongoing association studies (Specific Aim 3). Specimens will be sent to the NIMH repository for transformation and DNA extraction. Data collection and quality control will be maintained and verified data will be regularly uploaded to the NIMH repository (Specific Aim 4). The MGI augments other samples available with similar measures to confirm and extend present findings. In addition, the phenotypic characterization of participants with neurobehavioral and neuroimaging data will enable evaluation of the relation between genetic influences on neurobiological abnormalities and clinical manifestations. Finding additional potential quantitative markers for genetic vulnerability could improve our understanding of how genes related to brain development and regulation interact with environment in conferring SCZ susceptibility. Such efforts will enhance the integration of neurobiologic and genetic paradigms in human and animal research. In turn, this may pave the way for risk prediction and better treatment.

Public Health Relevance

Schizophrenia is a complex brain disorder that commonly emerges in adolescence and early adulthood and has devastating effects on the individual and family. Understanding the genetic basis of the deficits in brain function is key to early detection and to advance treatments that may improve outcome. The goal of the Multiplex Multigenerational Investigation of the schizophrenia consortium is to integrate neurobehavioral and neuroimaging methods in high-risk families that will yield the data needed for progress in the field.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-HOP-V (60))
Program Officer
Senthil, Geetha
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Texas Biomedical Research Institute
San Antonio
United States
Zip Code
Kos, Mark Z; Carless, Melanie A; Peralta, Juan et al. (2016) Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk. Schizophr Bull 42:288-300
Roalf, David R; Vandekar, Simon N; Almasy, Laura et al. (2015) Heritability of subcortical and limbic brain volume and shape in multiplex-multigenerational families with schizophrenia. Biol Psychiatry 77:137-46
Glahn, David C; Knowles, Emma E M; McKay, D Reese et al. (2014) Arguments for the sake of endophenotypes: examining common misconceptions about the use of endophenotypes in psychiatric genetics. Am J Med Genet B Neuropsychiatr Genet 165B:122-30
Roalf, David R; Ruparel, Kosha; Gur, Raquel E et al. (2014) Neuroimaging predictors of cognitive performance across a standardized neurocognitive battery. Neuropsychology 28:161-76
Roalf, David R; Gur, Ruben C; Almasy, Laura et al. (2013) Neurocognitive performance stability in a multiplex multigenerational study of schizophrenia. Schizophr Bull 39:1008-17
Yokley, Jessica L; Prasad, Konasale M; Chowdari, Kodavali V et al. (2012) Genetic associations between neuregulin-1 SNPs and neurocognitive function in multigenerational, multiplex schizophrenia families. Psychiatr Genet 22:70-81
Da Silva, Felipe N; Irani, Farzin; Richard, Jan et al. (2012) More than just tapping: index finger-tapping measures procedural learning in schizophrenia. Schizophr Res 137:234-40
Tarbox, Sarah I; Almasy, Laura; Gur, Raquel E et al. (2012) The nature of schizotypy among multigenerational multiplex schizophrenia families. J Abnorm Psychol 121:396-406
Irani, Farzin; Brensinger, Colleen M; Richard, Jan et al. (2012) Computerized neurocognitive test performance in schizophrenia: a lifespan analysis. Am J Geriatr Psychiatry 20:41-52
Drago, Antonio; Giegling, Ina; Schäfer, Martin et al. (2012) No association of a set of candidate genes on haloperidol side effects. PLoS One 7:e44853

Showing the most recent 10 out of 22 publications